ZKJ-29788-14934

3 vaccinations 11 coded responses 39 check-ins 11 free-text entries 3 call cases

Sex: Female
Age at first dose: 31-35
ZIP prefix: 481 / MI
Registered: 2020-12-23

Relationship: Self
Race: White
Ethnicity: Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-23
Registered in v-safe
2020-12-23
Dose 1 — Pfizer-BioNTech
2020-12-23
Health check-in — day 0, dose 1
Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness

Adult check-in
2020-12-24
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Fatigue or tiredness, Nausea

Adult check-in
2020-12-25
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness

Adult check-in
2020-12-26
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness

Adult check-in
2020-12-27
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Nausea, Abdominal pain

Adult check-in
2020-12-28
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness

Adult check-in
2020-12-29
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea

Adult check-in
2020-12-30
Health check-in — day 7, dose 1
Feeling: Fair · Headache, Fatigue or tiredness

Adult check-in
2021-01-08
Survey response — day 14, dose 1
MedDRA: Oral herpes — Feeling: Good

Free text: I had a cold sore surface after not having one in over 3 years.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-13
Dose 2 — Pfizer-BioNTech
2021-01-13
Health check-in — day 0, dose 2
Feeling: Good · Site: Pain · Fever · Chills, Fatigue or tiredness, Diarrhea, Abdominal pain

Adult check-in
2021-01-14
Survey response — days 1–6 daily, dose 2
MedDRA: Vision blurred — Feeling: Poor · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Blurred vision

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-14
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-01-15
Survey response — days 1–6 daily, dose 2
MedDRA: Anger, Mood swings — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness

Free text: Mood swings; short tempered

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-16
Survey response — days 1–6 daily, dose 2
MedDRA: Herpes simplex — Feeling: Good · Headache, Fatigue or tiredness

Free text: Oral HSV flare up

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-17
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activities

Adult check-in
2021-01-17
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-01-18
Survey response — days 1–6 daily, dose 2
MedDRA: Oral herpes — Feeling: Good · Headache, Fatigue or tiredness

Free text: Cold sore outbreak on lips

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-19
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-01-20
Health check-in — day 7, dose 2
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-01-27
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-04
Survey response — day 21, dose 2
MedDRA: Fatigue, Headache — Feeling: Fair · Be unable to do your normal daily activities

Free text: Increased fatigue and headaches

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-10
Survey response — day 28, dose 2
MedDRA: Fatigue, Headache — Feeling: Fair

Free text: I am still generally fatigued and have a slight headache that is continuous.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-17
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-02-24
Health check-in — day 42, dose 2
Feeling: Fair

Adult check-in
2021-04-14
Health check-in — 3 months, dose 2
Feeling: Fair

Adult check-in
2021-07-14
Survey response — 6 months, dose 2
MedDRA: Hormone level abnormal, SARS-CoV-2 test positive — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: I tested positive for Covid back in April and have been having vaginal pH imbalances

MedDRA releases: 2021-09,2024-11 · check-in free text available
2022-01-13
Survey response — 12 months, dose 2
MedDRA: SARS-CoV-2 test positive — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Positive COVID-19 test for a second time

MedDRA releases: 2024-11 · check-in free text available
2022-04-20
Dose 3 — Pfizer-BioNTech
2022-04-21
Health check-in — days 1–6 daily, dose 3
Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2022-04-22
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness

Adult check-in
2022-04-23
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain · Headache, Fatigue or tiredness

Adult check-in
2022-04-24
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain · Headache

Adult check-in
2022-04-25
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain · None

Adult check-in
2022-04-26
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain · Headache

Adult check-in
2022-04-27
Health check-in — day 7, dose 3
Feeling: Good · None

Adult check-in
2022-05-04
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2022-05-12
Survey response — day 21, dose 3
MedDRA: Headache, Malaise, Nasal congestion, Oropharyngeal pain, Rhinorrhoea — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: General malaise, headache, sore throat, and runny/stuffy nose.

MedDRA releases: 2024-11 · check-in free text available
2022-05-18
Health check-in — day 28, dose 3
Feeling: Fair

Adult check-in
2022-05-25
Health check-in — day 35, dose 3
Feeling: Fair

Adult check-in
2022-06-01
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2022-07-22
Health check-in — 3 months, dose 3
Feeling: Good

Adult check-in
2022-10-21
Survey response — 6 months, dose 3
MedDRA: Conjunctivitis, Sinusitis, Upper respiratory tract infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Pink eye, sinus infection, upper respiratory infection all at the same time.

MedDRA releases: 2024-11 · check-in free text available
2022-10-21
Report sent to call center — 6 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-10-24
Call 1 — Requested Callback
2022-10-25
Call 2 — Left Voicemail
2022-10-25
Callback requested for
07:00PM ET

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-23	Pfizer-BioNTech
2	2021-01-13	Pfizer-BioNTech
3	2022-04-20	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2021-01-14	priority 2/3
2021-01-17	priority 2/3
2022-10-21	Unsuccessful

Free text

Release 1 — day 14, dose 1

2021-01-08

Symptoms: I had a cold sore surface after not having one in over 3 years.

Release 2 — days 1–6 daily, dose 2

2021-01-14

Systemic reaction (other): Blurred vision

2021-01-15

Systemic reaction (other): Mood swings; short tempered

2021-01-16

Systemic reaction (other): Oral HSV flare up

2021-01-18

Systemic reaction (other): Cold sore outbreak on lips

Release 3 — day 21, dose 2

2021-02-04

Symptoms: Increased fatigue and headaches

Release 4 — day 28, dose 2

2021-02-10

Symptoms: I am still generally fatigued and have a slight headache that is continuous.

Release 9 — 6 months, dose 2

2021-07-14

Symptoms: I tested positive for Covid back in April and have been having vaginal pH imbalances

Release 10 — 12 months, dose 2

2022-01-13

Symptoms: Positive COVID-19 test for a second time

Release 11 — day 21, dose 3

2022-05-12

Symptoms: General malaise, headache, sore throat, and runny/stuffy nose.

Release 12 — 6 months, dose 3

2022-10-21

Symptoms: Pink eye, sinus infection, upper respiratory infection all at the same time.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Conjunctivitis	·	·	✓
SD	Fatigue	✓	✓	✓
SD	Headache	✓	✓	✓
SD	Hormone level abnormal	✓	·	✓
SD	Malaise	·	·	✓
SD	Nasal congestion	·	·	✓
SD	Oral herpes	✓	✓	✓
SD	Oropharyngeal pain	·	·	✓
SD	Rhinorrhoea	·	·	✓
SD	SARS-CoV-2 test positive	✓	·	✓
SD	Sinusitis	·	·	✓
SD	Upper respiratory tract infection	·	·	✓
SRO	Anger	✓	✓	✓
SRO	Herpes simplex	✓	✓	✓
SRO	Mood swings	✓	✓	✓
SRO	Oral herpes	✓	✓	✓
SRO	Vision blurred	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release